ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.62M
Enterprise Value 34.02M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)-50.09
Price/Book (mrq)1.19
Enterprise Value/Revenue 3-20.93
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)712.50%

Management Effectiveness

Return on Assets (ttm)-9.61%
Return on Equity (ttm)-6.80%

Income Statement

Revenue (ttm)-192k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)8.38M
EBITDA N/A
Net Income Avi to Common (ttm)-571k
Diluted EPS (ttm)-0.0130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.73M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.90
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)2.41M
Levered Free Cash Flow (ttm)2.91M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.21
52-Week Change 3-34.38%
S&P500 52-Week Change 35.73%
52 Week High 30.3400
52 Week Low 30.2000
50-Day Moving Average 30.2400
200-Day Moving Average 30.2552

Share Statistics

Avg Vol (3 month) 347.36k
Avg Vol (10 day) 3202.91k
Shares Outstanding 544.21M
Float 30.67M
% Held by Insiders 110.61%
% Held by Institutions 122.81%
Shares Short (Apr 29, 2016) 4157.47k
Short Ratio (Apr 29, 2016) 41.03
Short % of Float (Apr 29, 2016) 40.41%
Short % of Shares Outstanding (Apr 29, 2016) 40.36%
Shares Short (prior month Mar 31, 2016) 4507.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 28, 2017
Ex-Dividend Date 4Dec 30, 2015
Last Split Factor (new per old) 21/1
Last Split Date 3Sep 29, 2017